IHE ISHARES TR
FollowU.S. PHARMA ETF (fund)
Filings received so far for Q3 2026: 7 13F filers report a position in IHE shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Cadent Capital Advisors, LLC | 35,010 | $3.52M | 0.75% | +32,507 | 13F-HRTimeline |
| Insight Wealth Strategies, LLC | 3,461 | $348K | 0.03% | -119,181 | 13F-HRTimeline |
| Farther Finance Advisors, LLC | 2,234 | $225K | <0.01% | +76 | 13F-HRTimeline |
| Prism Advisors, Inc. | 2,108 | $208K | 0.05% | 0 | 13F-HRTimeline |
| VALLEY WEALTH MANAGERS, INC.in group VALLEY WEALTH MANAGERS, INC. | 900 | $90.5K | 0.01% | 0 | 13F-HRTimelineGroup |
| CONGRESS ASSET MANAGEMENT CO | 55,779 | $55.8K | <0.01% | new | 13F-HRTimeline |
| CX Institutional | 445 | $45K | <0.01% | +13 | 13F-HRTimeline |